Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Medical Oncology

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-009-9331-8PMID 19830600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol

  2008cited by this paper
• Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore

  2008cited by this paper
• Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol

  2007cited by this paper
• Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.

  2006cited by this paper
• Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Clinical Utility of Thiopurine S-Methyltransferase Genotyping

  2004cited by this paper
• Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

  2004cited by this paper
• Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age

  2004cited by this paper
• [Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia].

  2003cited by this paper
• Thiopurine methyltransferase polymorphisms in a Brazilian population

  2003cited by this paper
• Thiopurine Methyltransferase Polymorphisms in a Multiracial Asian Population and Children With Acute Lymphoblastic Leukemia

  2002cited by this paper
• The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.

  2002cited by this paper
• Pharmacogenomics of childhood acute lymphoblastic leukemia.

  2001cited by this paper
• Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

  2001cited by this paper
• Pharmacogenomics of childhood acute lymphoblastic leukemia.

  2001cited by this paper
• Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

  2000cited by this paper
• Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.

  2000cited by this paper
• Thiopurine methyltransferase alleles in British and Ghanaian populations.

  1999cited by this paper
• The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

  1999cited by this paper
• Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

  1999cited by this paper
• Med Pediatr Oncol

  1999cited by this paper
• Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.

  1999cited by this paper
• Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

  1999cited by this paper
• Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

  1998cited by this paper
• Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population

  1998cited by this paper
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

  1997cited by this paper
• Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.

  1996cited by this paper
• Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

  1996cited by this paper
• Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.

  1995cited by this paper
• Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

  1980cited by this paper

• Autoimmune hepatitis in children: Guidelines of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN)

  2025cites this paper
• Clinical relevance of Thiopurine methyl transferase genotype testing for azathioprine in dermatology.

  2025cites this paper
• Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report.

  2023cites this paper
• Türk Akut Lenfoblastik Lösemili Erişkin Hastalarda İdame Tedavisi Toksisiteleri, MTHFR ve TPMT Genetik Polimorfizm Analizi ve Doz Manipülasyonlarının Sağkalım Sonuçlarına Etkisi

  2022influential citation
• Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis

  2021cites this paper
• PGPM_A_325813 1303..1313

  2021cites this paper
• NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy

  2021cites this paper
• NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series

  2020cites this paper
• TPMT and ITPA Gene Polymorphism and Their Adverse Events during Chemotherapy of Acute Lymphoblastic Leukemia among Bangladeshi Children

  2019cites this paper
• The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics

  2019cites this paper
• Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia

  2018cites this paper
• JGH Open: The dawn of a new era in publishing!

  2017cites this paper
• Nucleoside diphosphate‐linked moiety X‐type motif 15 C415T variant as a predictor for thiopurine‐induced toxicity in Indian patients

  2017cites this paper
• Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia.

  2017cites this paper
• Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease

  2017cites this paper
• PRE-SCREENING TPMT STATUS OF LIVER TRANSPLANT PATIENTS FOR AZATHIOPRINE THERAPY–A SINGLE CENTRE EXPERIENCE FROM SOUTH INDIA

  2017cites this paper
• TPMT Polymorphism: When Shield Becomes Weakness

  2016cites this paper
• Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.

  2016cites this paper
• Asia–Pacific consensus statements on Crohn's disease. Part 2: Management

  2016cites this paper
• A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine

  2015cites this paper
• Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.

  2015cites this paper
• Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study

  2015cites this paper
• RETRACTED: Clinical significance of ITPA rs67002563 polymorphism in patients with acute lymphoblastic leukemia treated with 6-mercaptopurine.

  2015cites this paper
• Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia

  2014influential citation
• Pharmacogenetics of childhood acute lymphoblastic leukemia.

  2014cites this paper
• Methylenetetrahydrofolate reductase gene haplotypes affect toxicity during maintenance therapy for childhood acute lymphoblastic leukemia in Japanese patients

  2014cites this paper
• New genetic markers for treatment personalization in pediatric Acute Lymphoblastic Leukemia

  2013cites this paper
• Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance

  2013cites this paper
• Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy.

  2012cites this paper
• Indian Society of Gastroenterology consensus on ulcerative colitis

  2012cites this paper
• The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.

  2012cites this paper
• Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia

  2012cites this paper
• Effects of Thiopurine S-methyltransferase Genetic Polymorphism on Mercaptopurine Therapy in Pediatric ALL

  2011cites this paper
• Thiopurine S‐methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6‐mercaptopurine doses during maintenance therapy: The Polish multicenter analysis

  2011cites this paper